Bonk (BNKK) risk factors
Item 1A of every Bonk, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors59 risks16 new2 reworded
Bonk, Inc. has adopted a high-stakes cryptocurrency treasury strategy focused on holding massive amounts of BONK tokens. The company's core dietary supplement business does not generate positive cash flow, creating heavy reliance on BONK token valuation and external financing. Substantial risks center on BONK token price volatility, regulatory and security threats, and potential classification of BONK as a security.
Filed Mar 31, 2026 - FY2024 10-K risk factors43 risks
The company faces severe going concern doubts with $348,816 in cash against an accumulated deficit of $115,090,347 as of December 31, 2024. Operations rely heavily on third-party contract manufacturers for wellness products like Safety Shot and Sure Shot Dietary Supplements. Regulatory scrutiny by the FDA, FTC, and state authorities heavily impacts marketing claims, labeling, and product compliance.
Filed Mar 28, 2025